These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7003602)

  • 1. The effects of salbutamol on some metabolic and endocrine patterns of diabetic subjects.
    Torella R; Grandillo F; Giugliano D; Improta L; Varricchio M
    Pharmacol Res Commun; 1980 Oct; 12(9):909-19. PubMed ID: 7003602
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of acetylsalicylic acid on plasma glucose, free fatty acid, betahydroxybutyrate, glucagon and C-peptide responses to salbutamol in insulin-dependent diabetic subjects.
    Giugliano D; Passariello N; Torella R; Cerciello T; Varricchio M; Sgambato S
    Acta Diabetol Lat; 1981; 18(1):27-36. PubMed ID: 7211088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ketogenic action of glucagon in insulin-dependent diabetic subjects.
    Harano Y; Ohgaku S; Shimizu Y; Izumi K; Takahashi J
    Endocrinol Jpn; 1977 Apr; 24(2):121-8. PubMed ID: 406133
    [No Abstract]   [Full Text] [Related]  

  • 4. [Metabolic risks of salbutamol in diabetic patients. A study using somatostatin (author's transl)].
    Schlienger JL; Compagnie MJ; Dellenbach P; Stephan F
    Nouv Presse Med; 1980 Sep; 9(32):2247-51. PubMed ID: 6106923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucose utilization during exercise in normal and diabetic subjects. The role of insulin.
    Krzentowski G; Pirnay F; Pallikarakis N; Luyckx AS; Lacroix M; Mosora F; Lefèbvre PJ
    Diabetes; 1981 Dec; 30(12):983-9. PubMed ID: 7030833
    [No Abstract]   [Full Text] [Related]  

  • 6. A 6-hour nocturnal interruption of a continuous subcutaneous insulin infusion: 2. Marked attenuation of the metabolic deterioration by somatostatin.
    Scheen AJ; Krzentowski G; Castillo M; Lefèbvre PJ; Luyckx AS
    Diabetologia; 1983 May; 24(5):319-25. PubMed ID: 6135635
    [No Abstract]   [Full Text] [Related]  

  • 7. Plasma glucagon in diabetes resulting from total pancreatectomy [proceedings].
    Bloom SR; Barnes AJ; Bryant MG; Alberti KG
    Metabolism; 1976 Nov; 25(11 Suppl 1):1481-2. PubMed ID: 979652
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of oral alanine on blood beta-hydroxybutyrate and plasma glucose, insulin, free fatty acids, and growth hormone in normal and diabetic subjects.
    Genuth SM; Castro J
    Metabolism; 1974 Apr; 23(4):375-86. PubMed ID: 4206148
    [No Abstract]   [Full Text] [Related]  

  • 9. Metabolic and circulatory effects of oral salbutamol in the third trimester of pregnancy in diabetic and non-diabetic women.
    Wager J; Fredholm BB; Lunell NO; Persson B
    Br J Obstet Gynaecol; 1981 Apr; 88(4):352-61. PubMed ID: 6261782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ketosis-resistance in fibro-calculous-pancreatic-diabetes. 1. Clinical observations and endocrine-metabolic measurements during oral glucose tolerance test.
    Yajnik CS; Shelgikar KM; Naik SS; Kanitkar SV; Orskov H; Alberti KG; Hockaday TD
    Diabetes Res Clin Pract; 1992 Feb; 15(2):149-56. PubMed ID: 1563331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The regulation of plasma ketone body concentration by counterregulatory hormones in man.
    Schade DS; Eaton RP
    Diabetes; 1977 Oct; 26(10):989-96. PubMed ID: 908465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of insulin in the metabolic response to exercise in diabetic man.
    Zinman B; Vranic M; Albisser AM; Leibel BS; Marliss ED
    Diabetes; 1979 Jan; 28 Suppl 1():76-81. PubMed ID: 761718
    [No Abstract]   [Full Text] [Related]  

  • 13. Metabolic effects of oral salbutamol in late pregnancy.
    Lunell NO; Wager J; Fredholm BB; Persson B
    Eur J Clin Pharmacol; 1978 Nov; 14(2):95-9. PubMed ID: 214306
    [No Abstract]   [Full Text] [Related]  

  • 14. [Blood levels of glucagon, insulin and nonesterified fatty acids after arginine stimulation in obese diabetics].
    Cucinotta D; Quartarone M; Saitta A; Sardo A; Squadrito G
    Boll Soc Ital Biol Sper; 1978 Nov; 54(22):2290-6. PubMed ID: 754729
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of acetylsalicylic acid on blood glucose, plasma FFA, glycerol, 3-hydroxybutyrate, alanine, C-peptide, glucagon and growth hormone responses to arginine in insulin-dependent diabetics.
    Giugliano D; Luyckx AS; Lefebvre PJ
    Diabete Metab; 1980 Mar; 6(1):39-46. PubMed ID: 6989660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of adrenergic beta-blocking agents on the serum insulin and glucagon response to oral glucose load in normal and diabetic subjects].
    Ferlito S; Volpicelli D; Del Campo F; Romano F; Modica L
    Clin Ter; 1981 May; 97(4):333-47. PubMed ID: 6113914
    [No Abstract]   [Full Text] [Related]  

  • 17. The regulation of plasma ketone body concentration by counter-regulatory hormones in man. II. Effects of growth hormone in diabetic man.
    Schade DS; Eaton RP; Peake GT
    Diabetes; 1978 Sep; 27(9):916-24. PubMed ID: 689302
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of glucagon in human diabetic ketoacidosis: studies using somatostatin.
    Gerich JE; Schneider VS; Lorenzi M; Tsalikian E; Karam JH; Bier DM; Forsham PH
    Clin Endocrinol (Oxf); 1976; 5 Suppl():299S-305S. PubMed ID: 829924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diurnal variations of serum insulin, total glucagon, cortisol, glucose and free fatty acids in normal and diabetic subjects before and after treatment with chlorpropamide.
    Loreti L; Sugase T; Foà PP
    Horm Res; 1974; 5(5):278-92. PubMed ID: 4851417
    [No Abstract]   [Full Text] [Related]  

  • 20. Glucose metabolism during the starved-to-fed transition in obese patients with NIDDM.
    Féry F; Balasse EO
    Diabetes; 1994 Dec; 43(12):1418-25. PubMed ID: 7958493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.